RootPath Genomics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in developing a personalized T-cell therapy platform that integrates precision medicine with cancer immunotherapy. The company's innovative technologies focus on the analysis and manipulation of individual immune cells, enabling advancements in immune and cell therapy. By precisely monitoring and modulating the immune system, RootPath aims to enhance the diagnosis and treatment of cancer, contributing to significant improvements in patient outcomes.
Strongest Laser
Series B in 2025
Strongest Laser is a high-power fiber laser equipment developer.
Rona Therapeutics
Series B in 2025
Rona Therapeutics is an RNA therapeutics platform focused on the discovery, development, and commercialization of innovative RNA medicines. The company specializes in modular and programmable RNA therapies, offering services that encompass oligonucleotide therapies, RNA editing, and polymeric molecules. Rona Therapeutics aims to create transformative RNA treatments that can significantly alter disease management across various therapeutic areas. To achieve this, the company is developing advanced facilities to enhance nucleic acid synthesis, delivery systems, oligonucleotide chemical modification, and RNA biology. By fostering an environment that promotes innovation, Rona Therapeutics is dedicated to improving patient outcomes and supporting healthier, longer lives.
Hexaell Biotech
Series B in 2025
Hexaell Biotechnology Co., Ltd is a start-up specializing in stem cell technology and artificial organs, focusing on innovative solutions for severe liver diseases. The company has licensed advanced technologies for developing bio-artificial livers that aim to replace human liver function and treat liver failure. Hexaell's research is based on findings published in prominent scientific journals, and it has conducted pilot clinical studies involving six liver failure patients at leading hepatopathy centers in China. By employing cell differentiation and production techniques, Hexaell is committed to providing effective treatment options for those suffering from liver conditions.
C Ray Therapeutics
Series A in 2024
C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020.
Qinglan Jichuang
Seed Round in 2024
Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Full-Life Technologies
Debt Financing in 2024
Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.
Full-Life Technologies
Series B in 2024
Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.
Illumax
Series A in 2023
Illumax is a company that specialises in the research and development of single-serve chemiluminescence, single-serve flow fluorescence, and laboratory automation technologies. It also offers the industry an open ecological platform for chemiluminescence and flow fluorescence.
Jinjiang Electronic Technology
Series B in 2022
Jinjiang Electronic Technology is a med-tech company focused on the research and development as well as the manufacture of advanced medical equipment designed to enhance patient care in the field of cardiac electrophysiology. The company offers a range of innovative products, including a 3D cardiac mapping system, electrophysiology recording system, cardiac RF ablation generator, and irrigation pump. These devices provide comprehensive solutions aimed at diagnosing and treating arrhythmias, ultimately improving the quality of life for patients with heart conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.